Incyte Corporation
USD92.24
-3.35 (-3.50%)
CEO
William J. Meury
IPO Date
1993-11-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$94.70
Prev. Close
$95.59
Day Low
$92.19
Day High
$94.89
52W Low
$64.72
52W High
$112.29
Market Cap
$18.43B
Volume
1.94M
| 15,000 |
| $84.53 |
| 28 May 2026 | BIENAIME JEAN JACQUES | director | F-InKind | Disposed | 13,059 | $97.10 |
| 28 May 2026 | BIENAIME JEAN JACQUES | director | M-Exempt | Disposed | 15,000 | $84.53 |
| 21 May 2026 | Clancy Paul J | director | M-Exempt | Acquired | 15,000 | $84.53 |
| 21 May 2026 | Clancy Paul J | director | S-Sale | Disposed | 15,000 | $94.93 |
| 21 May 2026 | Clancy Paul J | director | M-Exempt | Disposed | 15,000 | $84.53 |
| 20 May 2026 | Stein Steven H | CMO & Head of Late-Stage Dev. | A-Award | Acquired | 44,124 | $0.00 |
| 20 May 2026 | CAGNONI PABLO J | President, Global Head of R&D | A-Award | Acquired | 31,517 | $0.00 |
| 11 May 2026 | BAKER BROS. ADVISORS LP | director, 10 percent owner: | M-Exempt | Acquired | 15,000 | $84.53 |
| Purchase |
| $1,001 - $15,000 |
| 5 Oct 2017 | Shelley Moore Capito | Shelley Moore Capito | Purchase | $1,001 - $15,000 |
| Disclosed | Representative | Office | Type | Amount |
|---|---|---|---|---|
| 2 Jun 2025 | Rob Bresnahan | Rob Bresnahan | Sale | $1,001 - $15,000 |
| 8 Oct 2024 | Ro Khanna | Ro Khanna | Sale | $1,001 - $15,000 |
| 5 Apr 2024 | Ro Khanna | Ro Khanna | Purchase | $1,001 - $15,000 |
| 8 Nov 2023 | Ro Khanna | Ro Khanna | Sale | $1,001 - $15,000 |
| 8 Nov 2023 | Ro Khanna | Ro Khanna | Sale | $1,001 - $15,000 |
| 6 Oct 2023 | Ro Khanna | Ro Khanna | Sale | $1,001 - $15,000 |
| 11 Jul 2023 | Ro Khanna | Ro Khanna | Purchase | $1,001 - $15,000 |
| 11 Jul 2023 | Ro Khanna | Ro Khanna | Purchase | $1,001 - $15,000 |
| 12 Jun 2023 | Ro Khanna | Ro Khanna | Purchase | $1,001 - $15,000 |
| 17 Apr 2023 | Daniel Goldman | Daniel Goldman | Sale | $1,001 - $15,000 |